株探米国株
日本語 英語
エドガーで原本を確認する
false00017890290001789029aeva:WarrantsToPurchaseMember2025-03-192025-03-190001789029us-gaap:CommonStockMember2025-03-192025-03-1900017890292025-03-192025-03-19

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 19, 2025

 

 

Aeva Technologies, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39204

84-3080757

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

555 Ellis Street

 

Mountain View, California

 

94043

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (650) 481-7070

 

Not Applicable

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common stock, par value $0.0001 per share

 

AEVA

 

The Nasdaq Stock Market LLC

Warrants to purchase common stock

 

AEVAW

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 2.02 Results of Operations and Financial Condition.

 

On March 19, 2025, Aeva Technologies, Inc. issued a press release announcing financial results for the quarter and the year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this Item 2.02.

 

The information set forth in Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

 

 

 

 

 

 

 

 

Exhibit Number

 

Description

99.1

 

Press Release dated March 19, 2025

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).


 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Aeva Technologies, Inc.

 

 

 

 

Date:

March 19, 2025

By:

/s/ Saurabh Sinha

 

 

 

Saurabh Sinha
Chief Financial Officer

 


EX-99.1 2 aeva-ex99_1.htm EX-99.1 EX-99.1

 

Exhibit 99.1

Aeva Reports Fourth Quarter and Full Year 2024 Results

Global Top 10 Passenger OEM Awarded Aeva a Development Program for Next Generation Global Vehicle Production Platform; OEM Letter of Intent to Aeva for Large Scale Production Program Award This Year

On Track with Daimler Truck’s Production Program Milestones with Aeva SOP in 2026; Deepened Collaboration with Torc to Advance Autonomous Truck Development

Expanded Collaboration with SICK AG on Precision Sensing for Industrial Robotics and Factory Automation Applications

MOUNTAIN VIEW, Calif., Mar. 19, 2025 – Aeva® (NASDAQ: AEVA), a leader in next-generation sensing and perception systems, today announced its fourth quarter and full year 2024 results.

Key Company Highlights

Selected by a Global Top 10 Passenger OEM for joint development of Aeva Atlas Ultra 4D LiDAR for the OEM’s global platform across multiple vehicle model lines. Secured a letter of intent from the OEM for large scale production program award opportunity expected this year, with Atlas Ultra SOP targeting 2027
On track with Daimler Truck’s series production program, delivered on all development milestones in 2024. Deepened collaboration with Torc on data share to strengthen the safety architecture for autonomous trucking applications
Expanded collaboration with SICK to incorporate Aeva’s FMCW technology across SICK’s portfolio of high accuracy contactless sensors for a broad range of robotics and factory automation applications in the $10+ Billion industrial automation market
Showcased Atlas Ultra, our latest 4D LiDAR that offers 3x the resolution and is 35% slimmer than the standard Atlas, enabling seamless and flexible integration for passenger cars
Demonstrated the industry-first functional 4D LiDAR behind-windshield integration with an automotive partner, leveraging Aeva’s small form factor, lower power consumption and passive cooling
Successful 2024 achievements with key commercial wins, product and supply chain maturity and financial results that exceeded targets

“Aeva in 2024 accelerated the growing adoption of FMCW technology, with expanded partnerships in automotive and our growing pace of new production wins in industrial robotics, security and infrastructure,” said Soroush Salehian, Co-founder and CEO at Aeva. “We are thrilled to start 2025 with our first award for a development program with a global top 10 passenger OEM for their next-generation production platform planned for multiple vehicle model lines. With our 4D LiDAR’s unique combination of performance, maturity and scalability, we believe 2025 is the year where Aeva will be in a strong position to further drive the automotive and industrial automation markets transition to FMCW and deliver a year of record revenues with significant growth, while reducing our spend.”

Fourth Quarter and Full Year 2024 Financial Highlights

Cash, Cash Equivalents and Marketable Securities
o
Cash, cash equivalents and marketable securities of $112.0 million and available facility of $125.0 million as of December 31, 2024
Revenue
o
Revenue of $2.7 million in Q4 2024, compared to revenue of $1.6 million in Q4 2023

 


 

o
Revenue of $9.1 million for full year 2024, compared to revenue of $4.3 million for full year 2023
GAAP and Non-GAAP Operating Loss*
o
GAAP operating loss of $34.2 million in Q4 2024, compared to GAAP operating loss of $36.8 million in Q4 2023
o
GAAP operating loss of $158.4 million for full year 2024, compared to GAAP operating loss of $147.8 million for full year 2023
o
Non-GAAP operating loss of $27.7 million in Q4 2024, compared to non-GAAP operating loss of $31.3 million in Q4 2023
o
Non-GAAP operating loss of $123.2 million for full year 2024, compared to non-GAAP operating loss of $124.1 million for full year 2023
GAAP and Non-GAAP Net Loss per Share*
o
GAAP net loss per share of $0.67 in Q4 2024, compared to GAAP net loss per share of $0.92 in Q4 2023
o
GAAP net loss per share of $2.85 for full year 2024, compared to GAAP net loss per share of $3.29 for full year 2023
o
Non-GAAP net loss per share of $0.49 in Q4 2024, compared to non-GAAP net loss per share of $0.59 in Q4 2023
o
Non-GAAP net loss per share of $2.17 for full year 2024, compared to non-GAAP net loss per share of $2.54 for full year 2023
Shares Outstanding
o
Weighted average shares outstanding of 54.0 million in Q4 2024 and 53.4 million for full year 2024

2025 Financial Outlook

Revenue in the range of $15 million to $18 million, representing growth of approximately 70% to 100% year-over-year

*Tables reconciling GAAP to non-GAAP measures are provided at the end of this release.

Conference Call Details

Aeva will host a conference call and live webcast to discuss results at 2:00 p.m. PT / 5:00 p.m. ET today, March 19, 2025. The live webcast and replay can be accessed at investors.aeva.com.

About Aeva Technologies, Inc. (NASDAQ: AEVA)

Aeva’s mission is to bring the next wave of perception to a broad range of applications from automated driving to industrial robotics, consumer electronics, consumer health, security and beyond. Aeva is transforming autonomy with its groundbreaking sensing and perception technology that integrates all key LiDAR components onto a silicon photonics chip in a compact module. Aeva 4D LiDAR sensors uniquely detect instant velocity in addition to 3D position, allowing autonomous devices like vehicles and robots to make more intelligent and safe decisions. For more information, visit www.aeva.com, or connect with us on X or LinkedIn.

Aeva, the Aeva logo, Aeva 4D LiDAR, Aeva Atlas, Aeries, Aeva Ultra Resolution, Aeva CoreVision, and Aeva X1 are trademarks/registered trademarks of Aeva, Inc. All rights reserved. Third-party trademarks are the property of their respective owners.

 

 

 


 

Forward-looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements in this press release include our beliefs regarding our financial position and operating performance and business objectives for 2025, along with our expectations with respect to the production agreements, including with Daimler Truck, as well as engagement and deployments with other customers and partners during 2025 and after, including the global top 10 passenger OEM mentioned in this press release and SICK AG, our future production plans, the timing of Atlas Ultra SOP and our ability to access capital under our preferred equity facility. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including, but not limited to: (i) the fact that Aeva is an early stage company with a history of operating losses and may never achieve profitability, (ii) Aeva’s limited operating history and limited history of shipping significant product volumes, (iii) the ability to implement business plans, forecasts, and other expectations and to identify and realize additional opportunities, (iv) the ability for Aeva to have its products selected for inclusion in OEM products, (v) the ability to manufacture at volumes and costs needed for commercial programs, (vi) no assurance that any of our customers will ever complete testing and validation with us or that we will receive any billings or revenues in connection with such programs or that such customers will continue such programs, (vii) the need to conclude definitive deployment or production agreements with potential customers, including those mentioned in this release, (viii) that any validation orders will result in larger orders, (ix) that any programs into which our products may be designed will result in significant end customer sales, (x) that any of the opportunities referenced in this press release will result in significant deployments of our products, (xi) unforeseen project delays or product issues, such as difficulties or delays in shipping, manufacturing or installation, (xii) end customer acceptance of the platform, (xiii) revenue recognition rules, (xiv) our ability to reduce costs and unforeseen expenses, and (xv) other material risks and other important factors that could affect our financial results that are further described in our filings with the SEC. Please refer to our filings with the SEC, including our most recent Form 10-K and Form 10-Q. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Aeva assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Aeva does not give any assurance that it will achieve its expectations.

Non-GAAP Information

In addition to our financial results determined in accordance with U.S. GAAP, we present non-GAAP operating loss and non-GAAP net loss per share. “Non-GAAP operating loss” is defined as GAAP operating loss before stock-based compensation and litigation settlement, net. “Non-GAAP net loss per share” is defined as non-GAAP net loss divided by weighted average shares outstanding, basic and diluted. “Non-GAAP net loss” is defined as GAAP net loss before stock-based compensation, litigation settlement, net and change in fair value of warrant liability.

We believe that non-GAAP operating loss and non-GAAP net loss per share, when taken together with the corresponding U.S. GAAP financial measures, provide meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our core business, results of operations, or outlook. We consider non-GAAP operating loss and non-GAAP net loss per share to be important measures because they help illustrate underlying trends in our business and our historical operating performance on a more consistent basis.

However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations, including that they exclude certain expenses that are required under GAAP, which adjustments reflect the exercise of judgment by management. In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP financial measures or ratios differently or may use other financial measures or ratios to evaluate their performance, all of which could reduce the usefulness of non-GAAP operating loss and non-GAAP net loss per share as tools for comparison.

 


 

Reconciliations are provided at the end of this release to the most directly comparable financial measures in accordance with U.S. GAAP. Investors are encouraged to review our U.S. GAAP financial measures and not to rely on any single financial measure to evaluate our business.

Contacts

Investors:

Andrew Fung

investors@aeva.ai

Media:

Michael Oldenburg

press@aeva.ai

 


 

AEVA TECHNOLOGIES, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

December 31,
2024

 

 

December 31,
2023

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

28,864

 

 

$

38,547

 

 

Marketable securities

 

 

83,143

 

 

 

182,481

 

 

Accounts receivable

 

 

1,187

 

 

 

628

 

 

Inventories

 

 

2,345

 

 

 

2,374

 

 

Other current assets

 

 

7,761

 

 

 

5,195

 

 

Total current assets

 

 

123,300

 

 

 

229,225

 

 

Operating lease right-of-use assets

 

 

3,826

 

 

 

7,289

 

 

Property, plant and equipment, net

 

 

10,332

 

 

 

12,114

 

 

Intangible assets, net

 

 

1,725

 

 

 

2,625

 

 

Other noncurrent assets

 

 

8,306

 

 

 

6,132

 

 

TOTAL ASSETS

 

$

147,489

 

 

$

257,385

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

Accounts payable

 

$

5,453

 

 

$

3,602

 

 

Accrued liabilities

 

 

5,710

 

 

 

2,648

 

 

Accrued employee costs

 

 

5,783

 

 

 

6,043

 

 

Lease liability, current portion

 

 

3,039

 

 

 

3,587

 

 

Other current liabilities

 

 

19,174

 

 

 

2,524

 

 

Total current liabilities

 

 

39,159

 

 

 

18,404

 

 

Lease liability, noncurrent portion

 

 

720

 

 

 

3,767

 

 

Warrant liability

 

 

8,258

 

 

 

6,772

 

 

TOTAL LIABILITIES

 

 

48,137

 

 

 

28,943

 

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

 

 

Common stock

 

 

6

 

 

 

5

 

 

Additional paid-in capital

 

 

711,160

 

 

 

688,124

 

 

Accumulated other comprehensive income (loss)

 

 

47

 

 

 

(87

)

 

Accumulated deficit

 

 

(611,861

)

 

 

(459,600

)

 

TOTAL STOCKHOLDERS’ EQUITY

 

 

99,352

 

 

 

228,442

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 

$

147,489

 

 

$

257,385

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

AEVA TECHNOLOGIES, INC.

 

Condensed Consolidated Statements of Operations

 

(Unaudited)

 

(In thousands, except share and per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31,

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenue

 

$

2,696

 

 

$

1,611

 

 

$

9,065

 

 

$

4,312

 

Cost of revenue (1)

 

 

3,525

 

 

 

2,483

 

 

 

12,855

 

 

 

10,198

 

    Gross loss

 

 

(829

)

 

 

(872

)

 

 

(3,790

)

 

 

(5,886

)

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses (1)

 

 

24,343

 

 

 

26,197

 

 

 

102,667

 

 

 

102,503

 

General and administrative expenses (1)

 

 

7,729

 

 

 

7,741

 

 

 

33,259

 

 

 

31,761

 

Selling and marketing expenses (1)

 

 

1,338

 

 

 

2,035

 

 

 

7,156

 

 

 

7,638

 

Litigation settlement, net (2)

 

 

 

 

 

 

 

 

11,500

 

 

 

 

Total operating expenses

 

 

33,410

 

 

 

35,973

 

 

 

154,582

 

 

 

141,902

 

Operating loss

 

 

(34,239

)

 

 

(36,845

)

 

 

(158,372

)

 

 

(147,788

)

Interest income

 

 

1,385

 

 

 

2,417

 

 

 

7,712

 

 

 

8,925

 

Other income (expense), net

 

 

(3,266

)

 

 

(10,538

)

 

 

(1,430

)

 

 

(10,470

)

Loss before income taxes

 

$

(36,120

)

 

$

(44,966

)

 

$

(152,090

)

 

$

(149,333

)

Income tax provision

 

 

26

 

 

 

 

 

 

171

 

 

 

 

Net loss

 

$

(36,146

)

 

$

(44,966

)

 

$

(152,261

)

 

$

(149,333

)

Net loss per share, basic and diluted

 

$

(0.67

)

 

$

(0.92

)

 

$

(2.85

)

 

$

(3.29

)

Weighted-average shares used in computing net loss per share, basic and diluted

 

 

53,986,214

 

 

 

49,007,105

 

 

 

53,359,685

 

 

 

45,412,155

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes stock-based compensation as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31,

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of revenue

 

$

71

 

 

$

107

 

 

$

279

 

 

$

965

 

Research and development expenses

 

 

4,218

 

 

 

4,043

 

 

 

16,657

 

 

 

16,760

 

General and administrative expenses

 

 

2,072

 

 

 

1,142

 

 

 

5,875

 

 

 

5,131

 

Selling and marketing expenses

 

 

217

 

 

 

230

 

 

 

897

 

 

 

819

 

Total stock-based compensation expense

 

$

6,578

 

 

$

5,522

 

 

$

23,708

 

 

$

23,675

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2) Relates to the settlement of litigation related to the de-SPAC transaction and Aeva's indemnification obligations related thereto.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

AEVA TECHNOLOGIES, INC.

 

Condensed Consolidated Statements of Cash Flows

 

(Unaudited)

 

(In thousands)

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$

(152,261

)

 

$

(149,333

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

5,480

 

 

 

4,622

 

Impairment of inventories

 

 

1,140

 

 

 

224

 

Fair value at issuance of Series A warrants

 

 

 

 

 

6,500

 

Change in fair value of warrant liabilities

 

 

1,486

 

 

 

182

 

Stock-based compensation

 

 

23,708

 

 

 

23,675

 

Amortization of right-of-use assets

 

 

3,463

 

 

 

3,108

 

Realized loss on available-for-sale securities

 

 

 

 

 

 

Amortization of premium and accretion of discount on available-for-sale securities, net

 

 

(3,537

)

 

 

(2,973

)

Other

 

 

563

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(559

)

 

 

2,259

 

Inventories

 

 

(1,111

)

 

 

353

 

Other current assets

 

 

(2,566

)

 

 

279

 

Other noncurrent assets

 

 

318

 

 

 

(270

)

Accounts payable

 

 

1,835

 

 

 

(1,592

)

Accrued liabilities

 

 

2,334

 

 

 

(6,415

)

Accrued employee costs

 

 

(260

)

 

 

1,322

 

Lease liability

 

 

(3,595

)

 

 

(3,097

)

Other current liabilities

 

 

16,649

 

 

 

2,330

 

Net cash used in operating activities

 

 

(106,913

)

 

 

(118,826

)

Cash flows from investing activities:

 

 

 

 

 

 

Purchase of property, plant and equipment

 

 

(5,107

)

 

 

(6,104

)

Purchase of non-marketable equity investments

 

 

 

 

 

(5,000

)

Purchase of available-for-sale securities

 

 

(79,980

)

 

 

(152,364

)

Proceeds from maturities of available-for-sale securities

 

 

182,988

 

 

 

232,745

 

Net cash provided by investing activities

 

 

97,901

 

 

 

69,277

 

Cash flows from financing activities:

 

 

 

 

 

 

Proceeds from issuance of stock in private placement

 

 

 

 

 

21,455

 

Transaction costs related to issuance of stock in private placement

 

 

 

 

 

(818

)

Payments of taxes withheld on net settled vesting of restricted stock units

 

 

(752

)

 

 

(199

)

Proceeds from exercise of stock options

 

 

81

 

 

 

238

 

Net cash (used in) provided by financing activities

 

 

(671

)

 

 

20,676

 

Net decrease in cash and cash equivalents

 

 

(9,683

)

 

 

(28,873

)

Beginning cash and cash equivalents

 

 

38,547

 

 

 

67,420

 

Ending cash and cash equivalents

 

$

28,864

 

 

$

38,547

 

 

 

 

 


 

AEVA TECHNOLOGIES, INC.

 

Reconciliation of GAAP to Non-GAAP Operating Results

 

(Unaudited)

 

(In thousands, except share and per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation from GAAP to non-GAAP operating loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31,

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP operating loss

 

$

(34,239

)

 

$

(36,845

)

 

$

(158,372

)

 

$

(147,788

)

Stock-based compensation

 

 

6,578

 

 

 

5,522

 

 

 

23,708

 

 

 

23,675

 

Litigation settlement, net

 

 

 

 

 

 

 

 

11,500

 

 

 

 

Non-GAAP operating loss

 

$

(27,661

)

 

$

(31,323

)

 

$

(123,164

)

 

$

(124,113

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation from GAAP to non-GAAP net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31,

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net loss

 

$

(36,146

)

 

$

(44,966

)

 

$

(152,261

)

 

$

(149,333

)

Stock-based compensation

 

 

6,578

 

 

 

5,522

 

 

 

23,708

 

 

 

23,675

 

Financing charges

 

 

 

 

 

3,788

 

 

 

 

 

 

3,788

 

Litigation settlement, net

 

 

 

 

 

 

 

 

11,500

 

 

 

 

Fair value at issuance of Series A warrants

 

 

 

 

 

6,500

 

 

 

 

 

 

6,500

 

Change in fair value of warrant liabilities

 

 

3,303

 

 

 

250

 

 

 

1,486

 

 

 

182

 

Non-GAAP net loss

 

$

(26,265

)

 

$

(28,906

)

 

$

(115,567

)

 

$

(115,188

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation between GAAP and non-GAAP net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31,

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Shares used in computing GAAP net loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

        Basic and diluted

 

 

53,986,214

 

 

 

49,007,105

 

 

 

53,359,685

 

 

 

45,412,155

 

GAAP net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

        Basic and diluted

 

$

(0.67

)

 

$

(0.92

)

 

$

(2.85

)

 

$

(3.29

)

Stock-based compensation

 

 

0.12

 

 

 

0.11

 

 

 

0.43

 

 

 

0.52

 

Financing charges

 

 

 

 

 

0.08

 

 

 

 

 

 

0.09

 

Litigation settlement, net

 

 

 

 

 

 

 

 

0.22

 

 

 

 

Fair value at issuance of Series A warrants

 

 

 

 

 

0.13

 

 

 

 

 

 

0.14

 

Change in fair value of warrant liability

 

 

0.06

 

 

 

0.01

 

 

 

0.03

 

 

 

 

Non-GAAP net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

        Basic and diluted

 

$

(0.49

)

 

$

(0.59

)

 

$

(2.17

)

 

$

(2.54

)